Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer

by Gleave Martin E, Rajput Ashish B, Fazli Ladan, Hurtado-Coll Antonio, Kwon Erika M, Miller Melinda A, Johnson Karynn, Agalliu Ilir, FitzGerald Liesel M, Cox Michael E, Ostrander Elaine A, Stanford Janet L, Huntsman David G
Published 2008-08-01

Divergent androgen regulation of unfolded protein response pathways drives prostate cancer

by Sheng, Xia, Arnoldussen, Yke Jildouw, Storm, Margrethe, Tesikova, Martina, Nenseth, Hatice Zeynep, Zhao, Sen, Fazli, Ladan, Rennie, Paul, Risberg, Bjørn, Wæhre, Håkon, Danielsen, Håvard, Mills, Ian G, Jin, Yang, Hotamisligil, Gökhan, Saatcioglu, Fahri
Published 2015

Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cells.

by Jiao, Jing, Hindoyan, Antreas, Wang, Shunyou, Tran, Linh M, Goldstein, Andrew S, Lawson, Devon, Chen, Donghui, Li, Yunfeng, Guo, Changyong, Zhang, Baohui, Fazli, Ladan, Gleave, Martin, Witte, Owen N, Garraway, Isla P, Wu, Hong
Published 2012

MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study.

by Eminaga, Okyaz, Wei, Wei, Hawley, Sarah J, Auman, Heidi, Newcomb, Lisa F, Simko, Jeff, Hurtado-Coll, Antonio, Troyer, Dean A, Carroll, Peter R, Gleave, Martin E, Lin, Daniel W, Nelson, Peter S, Thompson, Ian M, True, Lawrence D, McKenney, Jesse K, Feng, Ziding, Fazli, Ladan, Brooks, James D
Published 2016

Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH.

by Lotan, Tamara L, Wei, Wei, Ludkovski, Olga, Morais, Carlos L, Guedes, Liana B, Jamaspishvili, Tamara, Lopez, Karen, Hawley, Sarah T, Feng, Ziding, Fazli, Ladan, Hurtado-Coll, Antonio, McKenney, Jesse K, Simko, Jeffrey, Carroll, Peter R, Gleave, Martin, Lin, Daniel W, Nelson, Peter S, Thompson, Ian M, True, Lawrence D, Brooks, James D, Lance, Raymond, Troyer, Dean, Squire, Jeremy A
Published 2016

Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinoma.

by Chan, Emily, McKenney, Jesse K, Hawley, Sarah, Corrigan, Dillon, Auman, Heidi, Newcomb, Lisa F, Boyer, Hilary D, Carroll, Peter R, Cooperberg, Matthew R, Klein, Eric, Fazli, Ladan, Gleave, Martin E, Hurtado-Coll, Antonio, Simko, Jeffry P, Nelson, Peter S, Thompson, Ian M, Tretiakova, Maria S, Troyer, Dean, True, Lawrence D, Vakar-Lopez, Funda, Lin, Daniel W, Brooks, James D, Feng, Ziding, Nguyen, Jane K
Published 2022